Soon K Woo from Santa Clara, CA, age 68

License Records

Soon Gee Woo

License #:

CC-0002393 - Active

Category:

Accountancy

Issued Date:

Sep 27, 2000

Type:

C.P.A. Certificate

Name / Title

Company / Classification

Phones & Addresses

Soon Woo
Owner

Marvel International
Durable Goods

1135 S Main St # A, Los Angeles, CA 90015
Website: tpousa.com

Soon Woo
Owner

Tpo USA Accessory
Durable Goods

138 W 38Th St, Los Angeles, CA 90037

Soon Woo
Owner

Woo Sung Chiropractic Clinic
Offices and Clinics of Chiropractors

945 S Western Ave, Los Angeles, CA 90006
(323)7333311

Soon Woo
Owner

Marvel International

1135 S Main St #A, Los Angeles, CA 90015
(213)7410900

Soon Woo
Owner

Tpo USA Accessory
Importers

138 W 38 St, Los Angeles, CA 90037
(323)2380001, (323)2380004

Soon Woo
Principal

Cafe Orange
Eating Place

2716 W 235 St, Torrance, CA 90505

Soon P. Woo
President

FUTURE PROPERTY MANAGEMENT, INC

23719 Rdg Line Rd, Diamond Bar, CA 91765

Soon H. Woo
President

KOYS, INC

138 W 38 St, Los Angeles, CA 90037

Us Patents

Inhibitors Of Histone Deacetylase
view source
US Patent:

7595343, Sep 29, 2009
Filed:

Sep 12, 2002
Appl. No.:

10/242304
Inventors:

Daniel Delorme - St-Lazare, CA
Soon Hyung Woo - Foster City CA, US
Arkadii Vaisburg - Kirkland, CA
Oscar Moradei - Kirkland, CA
Silvana Leit - Kirkland, CA
Stephane Raeppel - Pierrefonds, CA
Sylvie Frechette - Lachine, CA
Giliane Bouchain - Beaconsfield, CA
Assignee:

MethylGene, Inc. - Quebec
International Classification:

C07C 211/51
C07D 239/24
C07D 239/72
C07D 403/12
C07D 403/14
C07D 413/14
C07D 417/14
C07D 409/12
C07D 405/12
A61K 31/505
A61K 31/506
A61K 31/53
A61K 31/136
A61K 31/166
A61P 35/00
US Classification:

514617, 564155, 564161, 549 59, 549 68, 549362, 549434, 544 50, 544196, 544113, 544353, 544358, 544264, 544283, 544 49, 544 90, 544105, 544180, 544359, 546139, 5462681, 546452, 548143, 548146, 548152, 548217, 548250, 5142242, 5142305, 5142312, 5142315, 514245, 51425212, 51425213, 5142631, 5142661, 514307, 514336, 514340, 514342, 514364, 514367, 514375, 514394, 514406, 514456, 514469, 514415, 514438, 514443
Abstract:

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Amidino Compounds As Cysteine Protease Inhibitors
view source
US Patent:

7662849, Feb 16, 2010
Filed:

Jun 4, 2004
Appl. No.:

10/559405
Inventors:

John W. Patterson - Mountain View CA, US
Soon H. Woo - Palo Alto CA, US
Assignee:

ViroBay, Inc. - Menlo Park CA
International Classification:

A61K 31/382
A61K 31/445
C07D 335/02
C07D 211/54
US Classification:

514432, 5142385, 514311, 514331, 514394, 514416, 514451, 514520, 544 59, 544163, 546134, 546230, 546286, 5483044, 548505, 548585, 549 13, 549426, 558392
Abstract:

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Inhibitors Of Histone Deacetylase
view source
US Patent:

7838520, Nov 23, 2010
Filed:

Mar 15, 2005
Appl. No.:

11/081095
Inventors:

Daniel Delorme - St-Lazare, CA
Soon Hyung Woo - Foster City CA, US
Arkadii Vaisburg - Kirkland, CA
Oscar Moradei - Kirkland, CA
Silvana Leit - Kirkland, CA
Stephane Raeppel - Pierrefonds, CA
Sylvie Frechette - Lachine, CA
Giliane Bouchain - Beaconsfield, CA
Zhihong Zhou - Kirkland, CA
Assignee:

MethylGene, Inc. - Montreal
International Classification:

C07D 239/42
C07D 213/02
C07D 209/14
C07D 277/08
C07D 295/02
C07D 401/10
C07D 403/10
C07C 233/07
A61K 31/505
A61K 31/33
A61K 31/186
A61K 31/4164
A61K 31/47
A61P 35/00
US Classification:

5142315, 514617, 514241, 51425201, 5142521, 514256, 514269, 514277, 514359, 544196, 544264, 544283, 544353, 5462681, 564155, 564161
Abstract:

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Inhibitors Of Histone Deacetylase
view source
US Patent:

7868204, Jan 11, 2011
Filed:

Mar 25, 2005
Appl. No.:

11/091025
Inventors:

Daniel Delorme - St-Lazare, CA
Soon Hyung Woo - Palo Alto CA, US
Arkadii Vaisburg - Kirkland, CA
Oscar Moradei - Kirkland, CA
Silvana Leit - Kirkland, CA
Stephane Raeppel - Pierrefonds, CA
Sylvie Frechette - Verdun, CA
Giliane Bouchain - Cedar Valley, CA
Assignee:

MethylGene Inc. - Montreal
International Classification:

C07C 211/51
C07C 211/36
C07D 295/02
C07D 263/02
C07D 273/02
C07D 317/06
C07D 317/48
C07D 319/18
A61K 31/136
A61K 31/166
A61K 31/34
A61K 31/357
A61P 35/00
US Classification:

564123, 564155, 564161, 514617, 5142312, 514364, 514374, 514380, 514406, 514438, 514463, 514464, 548131, 548215, 548221, 5483561, 549 68, 549362, 549434, 549478, 549479
Abstract:

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Sulfonamide Compounds As Cysteine Protease Inhibitors
view source
US Patent:

8163735, Apr 24, 2012
Filed:

Dec 1, 2005
Appl. No.:

11/792101
Inventors:

Soon H. Woo - Palo Alto CA, US
Randall W. Vivian - San Mateo CA, US
John O. Link - San Francisco CA, US
Assignee:

Virobay, Inc. - Menlo Park CA
International Classification:

A61K 31/495
A61K 31/55
A61K 31/18
A61K 31/5375
A61K 31/445
A61K 31/44
C07D 265/30
C07D 241/04
C07D 211/08
C07D 223/02
C07D 213/57
C07C 311/01
A61P 9/00
A61P 37/00
A61P 17/06
A61P 29/00
US Classification:

51421712, 5142378, 51425212, 514331, 514357, 514603, 540604, 544159, 544383, 546192, 546330, 564 86
Abstract:

The present invention is directed to compounds of formula (I) that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them. Wherein R3 is -alkylene-SO2NR5R6.

Inhibitors Of Histone Deacetylase
view source
US Patent:

20090181971, Jul 16, 2009
Filed:

Aug 13, 2007
Appl. No.:

11/837696
Inventors:

Daniel Delorme - St. Lazare, CA
Soon Hyung Woo - Palo Alto CA, US
Arkadii Vaisburg - Kirkland, CA
International Classification:

C07C 237/20
A61K 31/53
A61K 31/517
A61K 31/438
A61K 31/437
A61K 31/44
A61K 31/403
A61K 31/165
C07D 253/08
C07D 239/72
C07D 471/06
C07D 471/04
C07D 211/74
C07D 209/36
C12N 5/06
US Classification:

514243, 5142663, 514296, 514300, 514352, 514418, 514619, 544183, 544286, 546 99, 546113, 546309, 548485, 564163, 435375
Abstract:

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Di-Fluoro Containing Compounds As Cysteine Protease Inhibitors
view source
US Patent:

20140018421, Jan 16, 2014
Filed:

Dec 18, 2012
Appl. No.:

13/719024
Inventors:

Craig J. Mossman - Saratoga CA, US
Jie Liu - Shanghai, CN
Soon Hyung Woo - Palo Alto CA, US
Assignee:

ViroBay, Inc. - Menlo Park CA
International Classification:

C07C 255/46
US Classification:

514521, 558426
Abstract:

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Di-Fluoro Containing Compounds As Cysteine Protease Inhibitors
view source
US Patent:

20140221478, Aug 7, 2014
Filed:

Apr 7, 2014
Appl. No.:

14/247117
Inventors:

- Menlo Park CA, US
Craig J. Mossman - Saratoga CA, US
Jie Liu - Shanghai, CN
Soon Hyung Woo - Palo Alto CA, US
Assignee:

ViroBay, Inc. - Menlo Park CA
International Classification:

C07C 255/46
US Classification:

514521, 558426
Abstract:

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.